DLBCL GERMINAL CENTER B-CELL TYPE
Clinical trials for DLBCL GERMINAL CENTER B-CELL TYPE explained in plain language.
Never miss a new study
Get alerted when new DLBCL GERMINAL CENTER B-CELL TYPE trials appear
Sign up with your email to follow new studies for DLBCL GERMINAL CENTER B-CELL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human trial tests promising pill for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called SGR-1505 in adults with advanced B-cell cancers that have returned or stopped responding to previous treatments. The main goal is to find the highest safe dose and understand how the drug affects the body. Researchers…
Matched conditions: DLBCL GERMINAL CENTER B-CELL TYPE
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test new Two-Pronged attack on tough blood cancers
Disease control Recruiting nowThis is a small, early-stage study for adults with B-cell leukemia or lymphoma that has come back or not responded to other treatments. The goal is to test the safety of a new two-step approach. First, patients receive a targeted radioactive drug (131-I apamistamab), followed by …
Matched conditions: DLBCL GERMINAL CENTER B-CELL TYPE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC